Definitive Contract 75A50120C00060
Award Date 4/2/20
Potential Completion Date 11/30/20
Potential Value $570K
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Emeryville, CA 94608, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
25
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Orasure Technologies Inc. is valued at $710,310 to support the development of a rapid antigen test for COVID-19. The contract was awarded under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002 and will deliver research and development efforts towards a host-directed therapeutic to aid long-term outcomes from lung...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $19.3 million firm fixed price definitive contract to ANP Technologies Inc. to support the RADX TECH PROJECT #2620 for accelerated manufacturing scale-up of ANP Technologies' nano-intelligent detection system for COVID-19 antigen rapid testing. Performance will take place in Newark, Delaware over a two year period concluding in December 2022. No set aside designation or...
- This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Luminex Corporation is valued at $642,450.00. The contract supports the development of Luminex's ARIES SARS-CoV-2 assay under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002. Special Instructions 019 revised the description for mitigating long-term effects of respiratory distress and updated submission deadlines...
- Luminex Corporation was awarded a $642,450 firm fixed price definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to develop an extended panel for the Luminex NXTAG COVID-19 diagnostic test. The contract is being performed in Austin, Texas over a period of four months ending July 1, 2020. This award was made under Special Instructions 019 of the department's Easy Broad Agency Announcement BAA-20-100-SOL-0002, which...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Siemens Healthcare Diagnostics Inc. a $13 million firm fixed price purchase order to develop SARS-CoV-2 antigen tests for the Advia Centaur and Atellica IM systems. As the prime contractor, Siemens Healthcare Diagnostics will deliver coronavirus COVID-19 testing capabilities to support the agency's response efforts. The tests will be developed and the contract performed in Norwood,...
- Siemens Healthcare Diagnostics Inc. was awarded a definitive contract valued at six hundred two thousand two hundred seventy-five dollars by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to conduct research and development of an automated immunoassay to aid in mitigating the long-term effects of respiratory distress from COVID-19. The award was made under Special Instructions 019 to the department's Easy Broad Agency Announcement...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to ANP Technologies Inc., a minority-owned for-profit small business located in Newark, Delaware. The $1,599,533 firm-fixed-price contract will develop rapid, heat-stable handheld lateral flow immunoassays utilizing thermally stable recombinant proteins and nano-intelligent detection system technology to quickly detect various biological targets....
- Now Diagnostics, Inc. was awarded a firm fixed price definitive contract valued at $695,500 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to develop rapid and accurate point of care and over-the-counter tests for detection of SARS-CoV-2 antibodies in blood and achieve Emergency Use Authorization. The contract will support the agency's efforts to expand COVID-19 serology testing capacity nationwide under its NOW Diagnostics COVID-19...
- This $34,714,763.00 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Detect Inc. to advance the development of a second-generation, multi-analyte molecular SARS-CoV-2 and influenza A/B test that has a reduced time to result and increased sensitivity for use at home or in a point-of-care setting. The contract is not set aside. The award references a Broad Agency Announcement (BAA) issued by the Biomedical Advanced Research...
- The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $508,865.04 firm-fixed price contract to the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco, California. The contract is for research and development to multiplex CRISPR-Cas13A technology for an at-home viral diagnostic, in support of the agency's efforts to enable home-based diagnostics for SARS-CoV-2 acute infection. This...